Biểu đồ giá cổ phiếu MDGEF
MDGEF Tài chính
Medigene AG
$2.59
0%
$0
Tính đến ngày hôm nay:May 13, 15:53:42 GMT-4
Quay lại
Medigene AG (MDGEF) Tài chính
Thống kê chính
Giá đóng cửa trước
$2.59
Giá mở cửa
$2.59
Phạm vi ngày
$0.1 - $2.59
Phạm vi 52 tuần
$0.1 - $2.59
Khối lượng
10.0K
Khối lượng trung bình
0
Tỷ suất cổ tức
--
EPS (TTM)
-1.28
Vốn hóa thị trường
$38.1M
MEDIGENE AG là gì?
MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. The company employs 86 full-time employees The company went IPO on 2000-06-30. The firm focuses on the development of personalized T cell-based immunotherapies. The company develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The firm operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.
